INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Insmed's price to sales ratio was 23.2× on Nov 11, 2026, against 98.8× a year earlier. Over the last 5 years it ranged from 9.3× to 100.5×, with a median of 21.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 23.2× | −59.6 |
| 2025 | Dec 31, 2025 | 82.8× | +46.8 |
| 2024 | Dec 31, 2024 | 36.0× | +20.2 |
| 2023 | Dec 29, 2023 | 15.8× | +5.7 |
| 2022 | Dec 30, 2022 | 10.0× | −8.5 |
| 2021 | Dec 31, 2021 | 18.6× | −1.5 |
| 2020 | Dec 31, 2020 | 20.1× | −1.1 |
| 2019 | Dec 31, 2019 | 21.2× | −26.2 |
| 2014 | Apr 30, 2014 | 47.4× | −82.6 |
| 2013 | Jan 31, 2013 | 130.0× | −18.7 |
| 2012 | Dec 31, 2012 | 148.7× | +131.2 |
| 2011 | Dec 30, 2011 | 17.5× | +17.5 |
| 2010 | Dec 31, 2010 | 0.0× | – |
See a number that looks wrong?